OverviewSuggest Edit

CollPlant is a regenerative medicine company focused on 3D bioprinting of tissues and organs, and on developing and commercializing tissue repair products for orthobiologics, and advanced wound care markets. The Company's rhCollagen BioInk product line is used for 3D bioprinting of tissues and organs, and a Vergenix line of rhCollagen products includes a soft tissue repair matrix for treating tendinopathy and a wound repair matrix to promote an optimal healing of acute and chronic wounds.

TypePublic
Founded1981
HQNess Ziona, IL
Websitecollplant.com

Latest Updates

Employees (est.) (Mar 2018)39
Share Price (Dec 2019)$5 (-5%)

Key People/Management at CollPlant

Yehiel Tal

Yehiel Tal

Chief Executive Officer
Oded Shoseyov

Oded Shoseyov

Founder and Chief Scientist
Eran Rotem

Eran Rotem

Deputy CEO & Chief Financial Officer
Nadav Orr

Nadav Orr

Vice President of R&D
Ilana Belzar

Ilana Belzar

Chief Operations Officer
Philippe Bensimon

Philippe Bensimon

Vice President of Regulatory Affairs and Quality Assurance
Show more

CollPlant Office Locations

CollPlant has offices in Ness Ziona and New York
Ness Ziona, IL (HQ)
Pinhas Sapir St 3
New York, US
1185 Ave of the Americas 3rd Floor
Show all (2)

CollPlant Financials and Metrics

CollPlant Revenue

Market capitalization (10-Dec-2019)

19.0m

Closing stock price (10-Dec-2019)

5.0
CollPlant's current market capitalization is $19 m.
Show all financial metrics

CollPlant Online and Social Media Presence

Embed Graph

CollPlant News and Updates

CollPlant Reports Third Quarter 2019 Financial Results and Provides Business Update

REHOVOT, Israel, Nov. 29, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced financial results for the third quarter ended September 30, 2019 and provided an update on the Company's business developments. Certain metrics, including those...

CollPlant Reports First Quarter 2019 Financial Results and Provides Business Update

REHOVOT, Israel, May 30, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced financial results for the first quarter ended March 31, 2019 and provided an update on the Company's business developments. Certain metrics, including those expressed...

CollPlant Presents Its rhCollagen-based BioInks for 3D Bioprinting of Tissues and Organs at TERMIS Annual Meeting in Rhodes, Greece

REHOVOT, Israel, May 28, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced that Dr. Nadav Orr, the Company's Vice President for R&D, presented the utilization of CollPlant's recombinant human collagen (rhCollagen) in the field of 3D...

CollPlant Launches New HQ and R&D Center in Israel

REHOVOT, Israel, May 22, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, has launched a new HQ and R&D center in Israel. CollPlant is developing, manufacturing and commercializing products for tissue repair and organ manufacturing from its proprietary...

Regenerative medicine firm CollPlant launches Israel R&D centre

CollPlant, which makes products for tissue repair and organ manufacturing from its recombinant human collagen, has launched a new research and development centre in Israel.

CollPlant Announces Publication of Study in Science Translational Medicine Showing Composite Matrix Based on rhCollagen, Ceramics and Bone Morphogenic Protein Led to Bone Growth Superior to Standard of Care

REHOVOT, Israel, April 24, 2019 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative medicine company, today announced the publication of a study titled, "Bone Repair with a Receptor Optimized BMP-2/6/Activin Chimera Delivered In a Novel Ceramic/rhCollagen Matrix is Superior to BMP-2" ...
Show more

CollPlant Frequently Asked Questions

  • When was CollPlant founded?

    CollPlant was founded in 1981.

  • Who are CollPlant key executives?

    CollPlant's key executives are Yehiel Tal, Oded Shoseyov and Eran Rotem.

  • How many employees does CollPlant have?

    CollPlant has 39 employees.

  • Who are CollPlant competitors?

    Competitors of CollPlant include Cytori Therapeutics, Pharmanutra and Delcath Systems.

  • Where is CollPlant headquarters?

    CollPlant headquarters is located at Pinhas Sapir St 3, Ness Ziona.

  • Where are CollPlant offices?

    CollPlant has offices in Ness Ziona and New York.

  • How many offices does CollPlant have?

    CollPlant has 2 offices.